CardioFocus’ HeartLight system to be featured at two upcoming arrhythmia conferences


CardioFocus has announced that recent data will be presented at two major conferences focusing on cardiac rhythm management, the 2014 Stanford Biodesign New Arrhythmia Technologies Retreat, being held May 6th in Stanford, USA, and 2014 Heart Rhythm Society (HRS) Scientific Sessions, being held May 7-10 in San Francisco, USA.

At the Stanford Biodesign forum, Vivek Reddy, of Mount Sinai Hospital and a principal investigator of CardioFocus’ Pivotal Trial of the HeartLight endoscopic ablation system, will discuss laser ablation of atrial fibrillation during a session entitled “Advances in Mapping and Ablation (Part II).” The session will be moderated by Andrea Natale, Texas Cardiac Arrhythmia Research Foundation, also a principal investigator of the same trial. The HeartLight US Pivotal trial, now midway through the 12-month follow-up phase, is scheduled to conclude before year end 2014. In addition, Stephen Sagon, president of CardioFocus, will be speaking during the Stanford Biodesign meeting about European results from the regular clinical use of the HeartLight system.

At the HRS Scientific Sessions, several oral and poster presentations will also be on the programme. Presentation authors will lead discussions featuring compelling clinical evidence regarding laser ablation, a unique technique to achieve durable pulmonary vein isolation. The HRS presentation details are as follows:


  • “Laser Ablation of the PVs: Techniques and Outcomes”
    Authors: Josef Kautzner. Institute for Clinical and Experimental Medicine, Prague, Czech Republic

    Session: AF04 – New and Old Technologies for AF Ablation
  • “Laser, Ultrasound Cryo Ablation, and Noninvasive Ablation”
    Authors: Paul J. Wang. Stanford University School of Medicine, Stanford, USA

    Session: 020 – New Arrhythmia Technologies
  • The Laser Balloon”
    Authors: Boris Schmidt. Cardioangiologisches Centrum Bethanien, Frankfurt/Main, Germany

    Session: 031 – Novel Technology to Treat Atrial Fibrillation


  • PO01 – Featured Poster Session and Reception

“Pulmonary vein orientation has a strong impact on medium-term atrial fibrillation free survival in patients undergoing endoscopic laser balloon ablation”
Poster: PO01-130

Authors: Pim Gal, et al.

“Pulmonary Vein Isolation Using a Visually-Guided Laser Balloon Catheter: Results of the US Feasibility Study”
Poster: PO01-141

Authors: Srinivas Dukkipati, et al.

  • PO02 – Poster Session II

“Anatomical predictors for successful pulmonary vein isolation using balloon-based ablation technologies”
Poster: PO02-89

Authors: Alexey Tsyganov, et al.

Stephen Sagon, president of CardioFocus, says, “We are very much looking forward to the Stanford Biodesign and Heart Rhythm meetings as they offer invaluable opportunities to discuss emerging technology with both researchers and practitioners. With more than 2,000 patients now treated in Europe using the HeartLight system, we are especially excited to hear from the many renowned cardiologists on the programme detailing cardiac advancements involving laser ablation and the HeartLight system.”